As regulators and payers increasingly elevate the importance of RWE in submission requirements and with an explosion of datasets opening up in parallel with advancing AI, deep learning, and large language models transforming big data analysis, it has never been more critical to keep up with the matrix of country-specific regulatory nuances and industry case studies in optimizing integrated evidence plans, bullet-proofing data quality, and navigating vendor selection.

The 2nd IMPACCT Real World Evidence Summit Europe is the only industry meeting dedicated to uniting experts in RWE and Evidence Generation to consolidate, innovate and apply RWE across the drug development lifecycle, from external control arms to reimbursement.

With a tight focus on leveraging AI for both efficiency gains and big data analysis, the latest on DARWIN and using RWE to support regulatory decision-making, and creating a robust integrated evidence strategy, join 60+ industry pioneers from AstraZeneca, Pfizer, Novartis, Sanofi and more to collaboratively establish best practice and bridge the evidence gap between clinical research and practice, ensuring resilience and success in a dynamic landscape as a successful business partner.